Clinical-scale selection of anti-CD3/CD28 - Activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor

Human Gene Therapy

Volumn 13, Issue 8, 2002, Pages 979-988

  Orchard, Paul J ^a   Blazar, Bruce R ^a,b   Burger, Scott ^b   Levine, Bruce ^c   Basso, Lisa ^a,b   Nelson, David M K ^d   Gordon, Keith ^a,b   McIvor, R Scott ^a   Wagner, John E ^a,b   Miller, Jeffrey S ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; NERVE GROWTH FACTOR RECEPTOR; RETROVIRUS VECTOR; THYMIDINE KINASE; VIRUS ENZYME; MICROSPHERE;

ANIMAL CELL; ARTICLE; BLOOD CELL; CELL ACTIVATION; CELL ASSAY; CELL COUNT; CENTRIFUGATION; CONTROLLED STUDY; DEVICE; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PURIFICATION; SERUM; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TIME; ANIMAL; CELL STRAIN 3T3; GENE VECTOR; GENETICS; GIBBON LEUKEMIA VIRUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MAGNETISM; METABOLISM; T LYMPHOCYTE;

3T3 CELLS; ANIMAL; ANTIGENS, CD28; ANTIGENS, CD3; CENTRIFUGATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LEUKEMIA VIRUS, GIBBON APE; LYMPHOCYTE ACTIVATION; MAGNETICS; MICE; MICROSPHERES; RECEPTOR, NERVE GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; THYMIDINE KINASE; TRANSDUCTION, GENETIC; ANIMALS;

ANIMALIA; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0036000333     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340252939087     Document Type: Article

References (48)

1. Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma
2. Centrifugal enhancement of retroviral mediated gene transfer
3. Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope
4. Hsv-tk gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
5. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes
6. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes
7. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting
8. Unrelated donor bone marrow transplantation for hematological malignancies-current status
9. Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells
10. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophag e colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
11. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective
12. Graft-versus-leukemia in bone marrow transplantation
13. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes
14. T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer
15. Graft-versus-leukemia reactions after bone marrow transplantation
16. High efficiency gene transfer into primary human tumor explants without cell selection
17. Rapid selection of antigen-specific T lymphocytes by retroviral transduction
18. Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation
19. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation
20. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro
21. T-cell depletion of HLA-identical transplants in leukemia
22. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts
23. Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer
24. Redesign of retroviral packaging lines to avoid recombination leading to helper virus production
25. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene
26. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
27. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral mediated gene transfer
28. Induction of abortive and productive proliferation in resting human T lymphocytes via CD3 and CD28
29. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
30. CD28 costimulation prevents cell death during primary T cell activation
31. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: Identification and isolation of effector subsets
32. Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus
33. T cell activation modulates retrovirus-mediated gene expression
34. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response
35. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
36. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma
37. Infectious retrovirus is inactivated by serum but not by cerebrospinal fluid or fluid from tumor bed in patients with malignant glioma
38. Isolation and expression of an altered mouse dihydrofolate reductase cDNA
39. HIV-1 replication is controlled at the level of T cell activation and proviral integration
40. Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex virus thymidine kinase gene
41. Use of suicide gene-expressing donor T-cells to control alloreactivity after haematopoietic stem cell transplantation
42. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study
43. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft
44. Efficient transfer of selectable and membrane reporter genes in hematopoietic progenitor and stem cells purified from human peripheral blood
45. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: Clinical follow-up and improved new vectors
46. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate
47. Induction of anergy in resting human T lymphocytes by immobilized anti- CD3 antibodies
48. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12